Navigation Links
Cancer Cases Dropped After Nuke Plant Closed: Study
Date:4/3/2013

WEDNESDAY, April 3 (HealthDay News) -- There were about 4,300 fewer than expected cases of cancer among people in Sacramento County, Calif., in the two decades after the closure of the Rancho Seco nuclear reactor, according to a new study.

The researchers found declines in cancer incidence in 28 of 31 categories, including notable drops in cancer among women, children and Hispanics.

The findings from the first long-term study of the full-population health impacts of the closure of a U.S. nuclear reactor show the need for a full review of the risks posed by low-level radiation, said study authors Joseph Mangano, an epidemiologist and executive director of the Radiation and Public Health Project, and Dr. Janette Sherman, an internist and toxicologist.

Declines in cancer cases among both males and females were seen in Sacramento County after the Rancho Seco nuclear plant closed more than 23 years ago. Because the decline was four times greater among women than men, however, it was deemed statistically significant only for females.

Breast and thyroid cancers were among the four types of cancer that showed a significant decrease among females, according to the study, published online recently in the journal Biomedicine International.

Between 1988 and 1994, the cancer rate among children aged 19 and younger in Sacramento County fell from nearly 18 to about 15 cases per 100,000, a drop of nearly 14 percent. During the same period, the California state rate did not change, the investigators found.

Over the next two five-year periods, the cancer rate among children in the county continued to fall before rising from 2005 to 2009 to a level that was still lower than what is was in the late 1980s, the study authors said in a news release from the Radiation and Public Health Project.

The researchers said their findings are important for the millions of Americans who live around active and idled nuclear plants.

"The impact of reactors should be measured not only in terms of health, but also in terms of cost," Sherman said in the news release. "For example, the 4,319 fewer cancers than expected in Sacramento County during the first 20 years after the Rancho Seco closure translates into many millions saved in direct medical costs, reduction of productivity lost and additional savings associated with the value of a human life."

"With large numbers such as these -- and with the future of this source of power a matter of great public concern -- reports like this one must be followed by ongoing efforts to attain better understanding of potential improvements in public health after reactors are shut down," Sherman added.

Although the study found an association between the closing of the Rancho Seco nuclear reactor and a long-term decline in cancer incidence in the county, the researchers pointed out that additional research is needed to determine if there is a cause-and-effect relationship.

More information

The American Cancer Society has more about radiation and cancer.

-- Robert Preidt

SOURCE: Radiation and Public Health Project, news release, March 28, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Columbia experts at American Assoc. for Cancer Research 2013 Annual Meeting
2. Most Doctors Dont Help Lung Cancer Patients Quit Smoking: Survey
3. Lung Cancer Asbestos Victims Center Now Urges US Navy Veterans Who Were Exposed To Asbestos On A Ship And Now Have Any Kind Of Lung Cancer To Call Them About Compensation
4. Cisplatin-resistant cancer cells sensitive to experimental anticancer drugs, PARP inhibitors
5. Childs Cancer Often Causes Parents Severe Distress: Study
6. Lung Cancer Asbestos Victims Center Now Urges Families Of A Retired Factory Worker To Call Them If Their Loved One Has Lung Cancer And Was Exposed To Asbestos At Work
7. Breast Cancer Gene Tests Wont Help Most Women: Report
8. Princess Margaret breast cancer research finds new drug target companion prognostic test for hormone therapy resistance
9. Unique group for single fathers due to cancer offers support
10. More Evidence Shows Hormone Therapy May Increase Breast Cancer Risk
11. When Breast Cancer Spreads to Lungs, Surgery May Increase Survival
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cancer Cases Dropped After Nuke Plant Closed: Study
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the Law ... organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps our ... a forum to network with elder law attorneys nationwide,” said Somekh. , ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual ... in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon ... fun run is geared towards children of all ages; it is a non-competitive, non-timed ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: ... “America On The Brink” is the creation of published author, William Nowers. ... As a WWII veteran, he spent thirty years in the Navy. Following ...
(Date:10/12/2017)... ... ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s premier ... of the shoulder pad. The shoulder pad provides optimal support and full contact ... using cold therapy. By utilizing ice and water that is circulated from an insulated ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... HMP ... the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare ... City on October 11, 2017. , The annual award competition recognizes editorial and design ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading ... announced that its MyDario product is expected to appear on The Dr. ... The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show ... The segment ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing ... of targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek ...
Breaking Medicine Technology: